World Health Organization company blog
Long-acting injectable is effective in preventing HIV acquisition in women
The HIV Prevention Trials Network study (HPTN 084) on the safety and efficacy of the long-acting injectable antiretroviral drug cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected women, was stopped early by the trial Data and Safety Monitoring Board (DSMB) as results showed CAB LA to be…
- Points
- 157
- HN comments
- 29
- Submissions
- 1
- Cited by
- 0 commenters
Society, Policy & CultureTech Industry & Business2020
On Hacker News
| Submitted | Title on HN | Points | Comments |
|---|---|---|---|
| Dec 1, 2020 | Long-acting injectable is effective in preventing HIV acquisition in women by _Microft | 157 | 29 |
